𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DNA and RNA flow cytometric study in multiple myeloma. Clinical correlations

✍ Scribed by Agostino Tafuri; Jane Meyers; Burton J. Lee; Michael Andreeff

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
513 KB
Volume
67
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Flow-Cytometric DNA analysis in primary
Flow-Cytometric DNA analysis in primary breast carcinomas and clinicopthological correlations
✍ Sven-BΓΆrje Ewers; Eva LΓ₯ngstrΓΆm Baldetorp; Dick Killander πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 967 KB

## Abstract Flow‐cytometric DNA analyses of single cell nuclei were performed on nuclear suspensions prepared from biopsies of primary breast carcinomas in 638 patients. Propidium‐iodide‐stained cell nuclei were analysed in an Ortho 50‐H Cytofluorograph. The patients were staged by the TMN classifi

Cell cycle analysis of 932 flow cytometr
Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material: Correlations between flow cytometric, clinical, and pathologic variables
✍ Elisabeth Bergers; Paul J. van Diest; Jan P. A. Baak; for the MMMCP Collaborativ πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 868 KB

## BACKGROUND. Confusing data have been presented for breast cancer patients on correlations between DNA ploidy and the percentage of S-phase cells and other prognostic variables. The aim of this study was to compare DNA ploidy classification and cell cycle variables with clinical, classic, and qua

Expression of p170 protein in multiple m
Expression of p170 protein in multiple myeloma: A clinical study
✍ Dr Giovanni Ucci; Mario Petrini; Alberto Riccardi; Rosangela Invernizzi; Giovann πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 527 KB

The expression of the p 170 multidrug resistance protein by bone marrow plasma cells (BMPC) was assessed at clinical presentation in 53 patients with multiple myeloma (MM) using the C219 monoclonal antibody. Twenty-two of the 53 (41 per cent) patients had variable aliquots (1-60 per cent, median=6